Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 5, keine Gesamtzahl für „moderate“
Suchtreffer
Begriffe & Kennungen
Cerdelga · 4.5 · CYP2D6 inhibitors in EMs with mild or moderate hepatic impairment See sections 4.2, 4.3 and 4.4.
Eintrag öffnenCerdelga · 4.5 · CYP3A inhibitors in EMs with moderate or severe hepatic impairment See sections 4.2 and 4.3.
Eintrag öffnenCerdelga · 4.5 · Cerdelga is contraindicated in patients who are CYP2D6 IMs or EMs taking a strong or moderate CYP2D6 inhibitor
Eintrag öffnenCetrotide · 4.8 · Mild to moderate OHSS (WHO grade I or II) have been commonly reported and should be considered as an intrinsic
Eintrag öffnenCetrotide · 4.8 · Reproductive system and breast disorders Common: Mild to moderate OHSS (WHO grade I or II) can occur which is
Eintrag öffnenCibinqo · 4.5 · When 100 mg abrocitinib was administered concomitantly with fluvoxamine (a strong CYP2C19 and moderate CYP3A i
Eintrag öffnenClopidogrel / Acetylsalicylic acid Viatris (previously Clopidogrel / Acetylsalicylic acid Mylan) · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel BGR (previously Zylagren) · 4.5 · 5 interaction is uncertain. As a precaution concomitant use of strong or moderate CYP2C19 inhibitors should be
Eintrag öffnenClopidogrel BGR (previously Zylagren) · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel HCS · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel Krka d.d. (previously Zopya) · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel Krka · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel TAD · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel Taw Pharma (previously Clopidogrel Mylan) · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel Viatris (previously Clopidogrel Taw Pharma) · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include for example omeprazole and esomepraz
Eintrag öffnenClopidogrel Zentiva (previously Clopidogrel Winthrop) · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel ratiopharm · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenClopidogrel/Acetylsalicylic acid Zentiva (previously DuoCover) · 4.5 · Medicinal products that are strong or moderate CYP2C19 inhibitors include, for example, omeprazole and esomepr
Eintrag öffnenComtan · 4.8 · Usually the adverse reactions caused by entacapone are mild to moderate. In clinical studies the most common a
Eintrag öffnen